Literature DB >> 28983370

Resilience Through Squamous Cell Carcinoma and Rhabdomyosarcoma of Oral Cavity: A Unique Case Report.

Sidra Mumtaz Shaikh1, Sobia Faisal1, Iqbal A M Khyani2, Bushra Sikandar3.   

Abstract

Rhabdomyosarcoma (RMS) is a soft tissue neoplasm of mesenchymal origin. It is a commonly encountered malignant tumor amongst pediatric patients, yet relatively rare in adults. It usually involves the head and neck region, genitourinary organs and retroperitoneal structures. In adults, the most commonly affected area is the head and neck region. We present here a case of a 30-year-old male patient with a primary squamous cell carcinoma of the tongue (T1, N0, M1), successfully cured with surgery and chemoradiotherapy and later on development of metachronous ipsilateral lesion on the left lower alveolus. Biopsy was consistent with spindle cell RMS. Immunohistochemistry demonstrated positivity for desmin, vimentin and myogenin, thus confirming the mesenchymal origin. With the best of our literature search, this is an exceptional case presenting two malignant lesions with diverse genetic origins, diagnosed at stage 1 and giving a favorable outcome.

Entities:  

Keywords:  Alveolar rhabdomyosarcoma; Chemotherapy; Immunohistochemistry; Mesenchymal differentiation; Squamous cell carcinoma

Year:  2016        PMID: 28983370      PMCID: PMC5624705          DOI: 10.14740/wjon978w

Source DB:  PubMed          Journal:  World J Oncol        ISSN: 1920-4531


Introduction

Among the malignant oral cavity lesions, squamous cell carcinoma comprises the most common pathologic type, associated with significant morbidity, speech and swallowing disabilities. Despite recent diagnostic and therapeutic improvement, a 10% increase in mortality is observed in the last 5 years [1]. The increased mortality related to squamous cell carcinoma of tongue (SCCOT) is perhaps due to the fact that most cases (94.3%) present with locally invasive disease, with incidence rate highest amidst fourth and sixth decades of life [2]. Rhabdomyosarcoma (RMS) is a malignant soft tissue lesion occurring most frequently in children in the initial decades [3], with 250 new cases diagnosed in the United States per annum. However, it is a rare entity in adults and carries an adverse prognosis, possibly due to differences in histological subtypes, lack of treatment protocols and presentation in advanced stages [4]. This case elaborates long-term survival and management of a middle-aged man with a history of SCCOT. It was followed by a complete cure, with further development of spindle cell rhabdomyosarcoma (SC-RMS) of the oral cavity as a metachronous primary lesion. The depth of invasion, en block tumor resection and involvement of regional lymph nodes are the major dynamics to evaluate for prognosis and recurrence rate. Our case is unique because of its peculiar age of presentation of 30 years, along with its favorable survival of 8 years.

Case Report

A 30-year-old male, married, shop keeper by profession, smoker for the past 10 years with no known comorbids, presented at a tertiary care hospital in 2009 with a 2-month history of a painless ulcer along the left lateral border of the tongue. He was initially treated with antibiotics by his general practitioner which proved to be ineffective. Punch biopsy was performed under local anesthesia and the histopathological findings were consistent with grade 1 well-differentiated keratinizing SCCOT (Fig. 1). He underwent left-sided hemi-glossectomy with neck dissection. Three cycles of chemotherapy were given pre- and postoperatively. Furthermore, he underwent 35 cycles of radiotherapy.
Figure 1

Squamous cell carcinoma of tongue (SCCOT): H&E at 400 magnification showing (A) nest and cords of atypical squamous cells exhibiting pleomorphic vesicular nuclei with prominent nucleoli having abundant cytoplasm and keratin pearls and (B) individual cell keratinization.

Squamous cell carcinoma of tongue (SCCOT): H&E at 400 magnification showing (A) nest and cords of atypical squamous cells exhibiting pleomorphic vesicular nuclei with prominent nucleoli having abundant cytoplasm and keratin pearls and (B) individual cell keratinization. Patient was quite well and disease free for 4 years until 2013, when he noticed a pea-sized tender swelling on inner aspect of the left lower alveolus. The lesion was excised and biopsy showed polyploid pyogenic granuloma with no signs of malignancy. The swelling recurred within 4 months. Patient complained of progressive and painful enlargement of the lesion, loosening of teeth and decreased mouth opening. During intra-oral examination, three exophytic growths with smooth erythematous surface were found on left mandibular quadrant with the largest measuring about 3 × 2 cm, attached firmly on the alveolar bone with loss of canine and first and second premolars (Fig. 2). The smaller lesions measuring 1.5 × 1.5 and 1 × 1 cm were found on medial and posterior aspects, respectively. No extra-oral abnormality was observed and cervical lymph nodes were non-palpable. Incisional biopsy revealed spindle cell carcinoma. Complete surgical excision was planned. After all aseptic measures, patient lied in a supine position, intubated and anesthetized. Left-sided segmental mandibulectomy was performed through visor’s incision (transcervical approach). En block tumor resection was undertaken. Incision was extended caudally to approach level I, II and III lymph nodes. Bilateral supra-omohyoid neck dissection was performed. Titanium reconstruction plate was applied over the defect, followed by repair of the floor of the mouth. Neck incision was closed and drains were placed.
Figure 2

(A) A 3 × 2 cm growth at left mandibular quadrant with loss of canine, first and second premolars. (B) Site of previous hemi-glossectomy.

(A) A 3 × 2 cm growth at left mandibular quadrant with loss of canine, first and second premolars. (B) Site of previous hemi-glossectomy. Postoperatively, patient recovered uneventfully. Histopathological assessment showed sheets of atypical spindle cells with large hyperchromatic nuclei, prominent nucleoli and abundant eosinophilic cytoplasm (Fig. 3). Positive immunohistochemical features (Table 1, Figs. 4, 5) included vimentin, anti-smooth muscle antibody (ASMA), myogenin and desmin in tumor cells, consistent with diagnosis of SC-RMS.
Figure 3

(A) H&E at 100 magnifications shows sheets of neoplastic spindle cells. (B) H&E at 400 magnification shows clusters of atypical cells with hyperchromatic nuclei, abundant eosinophilic cytoplasm and increased nucleus to cytoplasmic ratio.

Table 1

Immunocytological Findings of the Resected Specimen

Immunological markersFindings
PanckNegative
Cytokeratin AE1/AE3Negative
Cytokeratin 8/18Negative
P63Negative
VimentinPositive
ASMAPositive
MyogeninPositive
CD34Negative
S-100Negative
DesminPositive
Figure 4

Immunohistochemistry (1). Tumor cells stain positive for (A) desmin, (B) myogenin, (C) ASMA, and (D) vimentin.

Figure 5

Immunohistochemistry (2). Tumor cells stain negative for (A) CK AE1/CK AE3 and (B) S-100.

(A) H&E at 100 magnifications shows sheets of neoplastic spindle cells. (B) H&E at 400 magnification shows clusters of atypical cells with hyperchromatic nuclei, abundant eosinophilic cytoplasm and increased nucleus to cytoplasmic ratio. Immunohistochemistry (1). Tumor cells stain positive for (A) desmin, (B) myogenin, (C) ASMA, and (D) vimentin. Immunohistochemistry (2). Tumor cells stain negative for (A) CK AE1/CK AE3 and (B) S-100. Follow-up CT scan at third month showed no evidence of focal mass or cervical lymphadenopathy. He was referred to oncology department where he underwent chemotherapy. The combination of vincristine, actinomycin D and cyclophosphamide was given. After three cycles, he developed chemotherapy-induced myelosuppression. Multiple transfusions were performed. Five cycles of the same regimen were repeated after restoration of hemodynamic status. After completion of chemoradiotherapy, he reported back to us 3 months later with exposed reconstruction plate that had stripped off along the margins of the flap (Fig. 6). The case was discussed with multidisciplinary teams for mandibular reconstruction using autologous cortical bone; however, the patient denied any further surgical procedure and requested for plate removal, which was then removed under general anesthesia. He later on developed fistula at the site of mandibular resection with sero-sanguinous discharge for which he was prescribed appropriate antibiotics after specimen culture. Thereafter, we lost contact of the patient.
Figure 6

Exposed reconstruction plate.

Exposed reconstruction plate.

Discussion

Neoplastic lesions of the oral cavity are one of the top 10 malignancies in the world, and second most common in Pakistan [5]. Squamous cell carcinoma is the most common histological type with approximately 48,300 new cases expected in 2016 [6]. Risk factors include alcohol, tobacco and betel nuts that play a significant role towards the development of premalignant lesion like sub mucosal fibrosis and leukoplakia [7]. The development of SCCOT in our patient is implicated with his smoking history (10 pack-years). Tumor size and depth of invasion, spread to regional lymph nodes, and negative tumor margin assessment contribute towards the prognosis and functional staging [8]. Cervical lymphadenopathy and extracapsular invasion carry poor prognosis in SCCOT [9]. The results of the study performed by Jerjes et al entailed nodal involvement in eight out of 10 deaths due to local spread of disease and in eight out of 11 deaths due to metastasis [10]. While a discrepancy exists in determining prognosis and survival rate with age of initial presentation [11], Jerjes et al concurred that younger patients tend to have a worse prognosis, while older patients are likely to die from other comorbid conditions especially cardiorespiratory failure [10]. The 5-year survival rate is estimated to be 45-50% [5]. In this peculiar case, our patient presented at the age of 30 years, with grade I, well-differentiated SCCOT (T1N1M0). He responded well to the combined approach, i.e., surgery and chemoradiotherapy. No recurrence was observed in the subsequent 4 years, until the diagnosis of RMS was made. RMS arises from the skeletal muscle precursor cells, derived from connective tissue mesenchyme. The tumor is third in frequency to Wilm’s and neuroblastoma for the pediatric neoplastic lesion. It affects head and neck, genital tract (sarcoma botryoid) retroperitoneal structures and appendicular skeleton in decreasing order of frequency. Oral cavity lesions account for 10-12% cases of RMS in head and neck region [12]. Its occurrence is a rare entity in adults with head and neck as the most frequent site involved [13]. Atypical mesenchymal proliferation during embryonic tissue development is believed to form histological aspects of RMS. On the basis of cellular growth pattern, RMS is divided into alveolar (ARMS), embryonal (ERMS), botryoid and pleomorphic types (PRMS) [12]. Agaram et al excluded SC-RMS from ERMS subtypes and categorized them as distinct pathologies due to genetic alterations in MYOD1 genes [14]. The histological pattern of SC-RMS included proliferating spindle cells with long fascicles having eosinophilic cytoplasm and interspersed rhabdomyoblasts [14, 15]. The etiological factors associated with SC-RMS are not yet known. Genetic defects are found to play a role in tumor development. Szuhai et al established MYOD1 mutations as the cause of adult SC-RMS. p.L122R mutations in the DNA binding domain of the MYOD1 gene initiate possible amplification of nuclear regulatory protein MYC. Both homozygous and heterozygous mutations can cause SC-RMS. MYOD1 gene regulates myocyte differentiation by transcribing nuclear protein complex and its mutation can lead to failure in cell cycle arrest which is a crucial stage in myogenic differentiation [16]. Conventionally, most head and neck squamous cell carcinomas (HNSCCs) are associated with TP53, NOTCH-1 and CKDN2A mutations. Yet in one of the studies performed by Vettore et al, DST and RNF213 mutations were more significant among Asian population, whereas NOTCH-1, CKDN2A and p53 alterations were uncommonly found [17]. Hence, no possible genetic correlation exists between oral tongue squamous cell carcinoma (OTSCC) and SC-RMS. The development of SC-RMS should be considered a distinctive pathologic lesion rather than the sequel of OTSCC. In our case, the external beam radiotherapy given for SCCOT probably acted as a “second hit” to a pre-existing dormant mutation. Due to financial constraints, genetic typing could not be performed to further confirm the hypothesis. Biopsy and immunohistochemistry constitute a great part in making a diagnosis. RMS is recognized on the basis of positivity for several immune markers including muscle specific actin, cytokeratin, myogenin, desmin, S-100 protein, vimentin and cytokeratin [15]. The histopathology in our case exhibited uniform positivity for ASMA, myogenin, desmin and vimentin that confirms cellular pattern of mesenchymal origin. S-100 was negative (thus differentiated from peripheral nerve sheath tumor) as well as cytokeratin AE1/AE3. Table 2 elaborates various stages of RMS on the basis of anatomical site of involvement, nodal status and metastasis according to International Rhabdomyosarcoma Study Group (IRSG) protocol [3].
Table 2

Stages of Rhabdomyosarcoma According to International Rhabdomyosarcoma Study Group (IRSG) [3]

StageLocationNodal statusMetastasis
Stage IOrbit, head and neck, non-parameningeal, and genitourinaryAny sizeN0 or N1No metastasis
Stage IIAny other site < 5 cmN0No metastasis
Stage IIIAny other site < 5 cmAny other site > 5 cmN1N0 or N1No metastasis
Stage IVTumor at any location and of any sizeN0 or N1M1
The treatment options related with disease outcome are less eminent for adult SC-RMS and the childhood management protocol is followed including gross resection with combined system chemotherapy and radiotherapy (except for ERMS). Outcome in children showed 70-80% remission, yet the survival rate for adult may vary between 35% and 45% [18]. In our patient, we performed segmental mandibulectomy for the tumor resection and approached level I, II and III lymph nodes via bilateral supra omohyoid dissection. This had facilitated us to acquire tumor free margins and also minimized morbidity associated with surgery. Postoperatively, the patient initially responded well to chemotherapy. There is no superior advantage of concomitant radiotherapy in group 1 patients having ERMS subtype [3]. The surviving group of patients with head and neck cancers can develop radiation-induced sarcoma. To establish a relation between the irradiation and malignancy, the lesion must arise in the irradiated area and should be different from the primary lesion being treated [19], with an average gap of around 3 - 4 years between the radiation therapy and the sarcoma development [20]. Thus, we propose that the SC-RMS presented in our case could have been caused by radiotherapy given for SCCOT, as the lesion arose in the radiation affected area, had a different histological subtype than the primary lesion, and presented after 4 years (metachronous). Reconstruction techniques include use of biocompatible alloplastic plates, vascularized and non-vascularized bone grafts. However, in majority of cases, plate exposure occurs, which increases the risk for infections and subsequent fistula formation between skin and oral cavity [21]. In our case report, patient experienced a similar outcome with fistula formation. Hence, combined technique is suggested in which free flaps comprising of the pectoralis major or sternocleidomastoid muscle are wrapped around the end of the plate to ensure better approximation and to decrease the rates of plate exposure [22]. Unlike the pediatric counterpart, adult SC-RMS has an aggressive course and is associated with an adverse prognosis with a 5-year survival rate of 47% compared to 82% in children [4]. Little et al assessed outcome following multimodality treatment in adult patients with RMS and established tumor size as an effective index of prognosis. A disease free survival rate of 57% was observed in patients having a tumor size of ≤ 5 cm compared to 26% for those with a size of > 5 cm [18]. En block tumor resection of localized lesion in stage I patients ensured a good 5-year disease free survival, while the contrary existed for stage IV. Stage II and III patients showed intermediary responses and hence it is essential to treat these patients with appropriate combination therapy [3]. Prior case reports related to mandibular RMS were reported in India [23, 24] which call for attention to the increased incidence of mandibular RMS in the South Asian population. However, these cases depicted primary malignant RMSs, whereas the presented case showed SC-RMS occurring as a metachronous neoplasm 4 years after the presentation of SCCOT. Additionally, the patient has had a prolonged survival of 8 years since the presentation of the initial lesion, which is an exceptionally rare situation.

Conclusion

The diagnosis of SC-RMS is challenging and increased caution is required amongst clinicians to diagnose lesions earlier on, therefore non-healing ulcers and growths should be sent for histopathological assessment. Immunohistochemistry plays a critical role in specifying various histologic subtypes. The evolution of SC-RMS as a distinct metachronous lesion raises concern for its possible association with prior radiotherapy and likewise dose should be appropriately adjusted and minimized. This case highlights the fact that early detection and surgical resection at initial stages of RMS in an adult can give promising results.
  22 in total

1.  Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.

Authors:  Waseem Jerjes; Tahwinder Upile; Aviva Petrie; Andrew Riskalla; Zaid Hamdoon; Michael Vourvachis; Kostas Karavidas; Amrita Jay; Ann Sandison; Gareth J Thomas; Nicholas Kalavrezos; Colin Hopper
Journal:  Head Neck Oncol       Date:  2010-04-20

2.  Spindle cell rhabdomyosarcoma in the hypopharynx of an adult.

Authors:  Ting-Ting Wu; Qin-Ying Wang; Shui-Hong Zhou; Zhou-Jun Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

3.  Reconstruction of mandibular defects.

Authors:  Harvey Chim; Christopher J Salgado; Samir Mardini; Hung-Chi Chen
Journal:  Semin Plast Surg       Date:  2010-05       Impact factor: 2.314

Review 4.  Metastasis of squamous cell carcinoma of the oral tongue.

Authors:  Daisuke Sano; Jeffrey N Myers
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

Review 5.  Radiation-induced sarcomas of the head and neck.

Authors:  Anuradha Thiagarajan; N Gopalakrishna Iyer
Journal:  World J Clin Oncol       Date:  2014-12-10

6.  Rhabdomyosarcoma of the oral cavity: a case report.

Authors:  Ozkan Miloglu; Sare Sipal Altas; Mustafa Cemil Buyukkurt; Burak Erdemci; Oguzhan Altun
Journal:  Eur J Dent       Date:  2011-07

7.  Immunohistochemical study of CD44s expression in oral squamous cell carcinoma-its correlation with prognostic parameters.

Authors:  Kn Hema; Kavita Rao; Hs Uma Devi; Ns Priya; T Smitha; Hs Sheethal
Journal:  J Oral Maxillofac Pathol       Date:  2014-05

Review 8.  Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature.

Authors:  Ewa Majchrzak; Bartosz Szybiak; Anna Wegner; Piotr Pienkowski; Jakub Pazdrowski; Lukasz Luczewski; Marcin Sowka; Pawel Golusinski; Julian Malicki; Wojciech Golusinski
Journal:  Radiol Oncol       Date:  2014-01-22       Impact factor: 2.991

Review 9.  Rhabdomyosarcoma in adolescent and young adult patients: current perspectives.

Authors:  Daniela Egas-Bejar; Winston W Huh
Journal:  Adolesc Health Med Ther       Date:  2014-06-17

Review 10.  MicroRNA expression and its implications for diagnosis and therapy of tongue squamous cell carcinoma.

Authors:  Xin Yu; Zheng Li
Journal:  J Cell Mol Med       Date:  2015-10-24       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.